spinning artificial spider silk - ksla · spinning artificial spider silk anna rising professor....
TRANSCRIPT
Spinning Artificial Spider Silk
Anna Rising
Professor
Spiders produce up to seven different kinds of silks
Rising and Johansson, Nat Chem Biol. 2015
NT CT
Repetitive part
The spider silk gland
Soluble protein at highconcentration (30-50%).
Unordered structure
Hijirida 1996; Rising 2014; Simmons 1996
Function: protein synthesis storage fiber formation
Spider silk is an attractive material
Material Tensile Strength
(Gpa)
Extensibility (%) Toughness (MJm-3)
Dragline silk 0.88-1.5 21-27 136-194
Kevlar 49 3.6 2.7 50
High tensile steel 1.5 0.8 6
Gosline J Exp Biol 1999; Blackledge J Exp Biol 2006; Denny 1976 J. Exp. Biol. , Köhler J. exp. Zool. 1995; Radke. PLoS ONE. 2011
• Extreme mechanical properties
• Low density
• Biodegradable
• Successfully used to enable nerve regeneration in animal models
https://www.wired.com/2009/09/spider-silk/
~ 1 x 3 m70 persons
4 years1 million spiders
1
cm
Euprosthenops australis
Rising & Johansson. Nat Chem Biol. 2015; Andersson et al PLoS Biol 2014; Kronqvist et al. Nat Commun. 2014
A broad and steep pH gradient
NT
CT
Rising & Johansson. Nat Chem Biol. 2015; Andersson et al PLoS Biol 2014; Kronqvist et al. Nat Commun. 2014
Spider silk formation is controlled by complex molecular mechanisms
NT
CT
LOCK
TRIGGER
NT CT
2 Rep
A successful design
Is efficiently produced in bacteria
Is extremely soluble and can be concentrated to >500 mg/ml (>50%) in an aqueous buffer, pH 7-8
Andersson, Jia et al. Nat Chem Biol. 2017
Andersson et al. Nat Chem Biol. 2017
An unexpected discovery…
Rising & Johansson. Nat Chem Biol. 2015
NT keeps the silk proteins in solution
NT
CT
NT
CT
Mimicking Nature’s own way of
producing sticky proteins
NT CT
NT
Johansson; Nordling, Kronqvist, Rising
• Lowers the surface tension
• Is composed of phospholids and a few specific
proteins
• Used to treat millions of prematurely born
infants
• Is produced from pig lungs
Lung surfactant
Whitsett et al. Annu Rev Pathol 2015; Kronqvist et al. Nat Commun. 2017
NT +
We can make large amounts of cheap lung surfactant
Development of novel treatment regimes for Acute Respiratory Distress Syndrome)
NT for industrial production of valuable proteins
Development of novel drug delivery systems to the lungs
Zebialowicz, Larsson, Antoni, Velikyan, Curstedt, Johansson et al. unpublished
• Karolinska Institutet: Janne Johansson, Tore Curstedt, Peter Bergman, Elisabet Åkesson, Mattias Sköld, Outi
Hovatta
• Uppsala Universitet: Anders Larsson, Gunnar Antoni, Irina Velikyan
• Latvian Institute of Organic Synthesis: Kristaps Jaudzems
• New York University: Mitchel Chesler
• Past and current group members: Marlene Andersson, Jakub Zebialowicz, Oihana Basabe Burgos, Pavol
Mikolka, Kerstin Nordling, Nina Kronqvist, Medoune Sarr, Mike Thorpe, Nathalie Gonska, Qiupin Jia, Gefei Chen
THANK YOU!